Telehealth Anxiety Prescribing: What Prescribers Can Do in Michigan

You’re a psychiatric mental health nurse practitioner (PMHNP) or considering becoming one, and you’re wondering: Can I prescribe anxiety medications? Or maybe you’re a psychiatrist curious about how your NP colleagues’ authority compares to yours. Here’s the straight answer: Yes, PMHNPs can prescribe anxiety medications, including controlled substances like benzodiazepines—but the rules vary dramatically by state.

Whether you can write that Lexapro prescription or initiate a patient on Xanax without a physician looking over your shoulder depends entirely on where you’re licensed. Some states give you full independence. Others require you to maintain a collaborative agreement with a psychiatrist or physician. And a few still impose restrictions on specific medication classes or quantities.

If you’re exploring telehealth opportunities or considering practice across multiple states, understanding these nuances isn’t just important—it’s essential to practicing legally and building a sustainable anxiety-focused practice.

The Three-Tier System: Where Does Your State Stand?

The United States operates under three distinct categories of nurse practitioner practice authority, and your prescribing freedom for anxiety medications falls squarely within these frameworks:

Full Practice Authority (FPA) States

In these states, you can evaluate, diagnose, and prescribe medications—including Schedule IV benzodiazepines—completely independently once you’re licensed and have your DEA registration. No physician collaboration agreement required. No mandatory chart reviews. You’re practicing to the full scope of your training.

Notable FPA states include:

• New York (as of 2022, removing all collaboration requirements)
• Arizona
• Washington
• Oregon
• Montana

In New York, for example, the Nurse Practitioner Modernization Act eliminated the 3,600-hour collaboration requirement entirely. A newly graduated PMHNP can now open their own anxiety treatment practice, prescribe SSRIs, SNRIs, buspirone, or benzodiazepines as clinically appropriate—with zero physician oversight beyond the standard of care.

Reduced Practice States

These states allow NPs to practice somewhat independently but require a formal collaborative agreement specifically for prescriptive authority. You’ll need a supervising or collaborating physician (ideally a psychiatrist for psychiatric prescribing) who reviews your work periodically and signs off on your authority to prescribe controlled substances.

Examples:

• Illinois has a unique pathway: new NPs need collaboration, but after 4,000 clinical hours and 250 hours of continuing education, you can apply for Full Practice Authority. Even then, you’ll need a one-time physician consultation agreement for prescribing benzodiazepines and Schedule II medications.

• California is mid-transition. Historically restrictive, AB 890 (effective 2023-2026) created two new categories: 103 NPs can practice without standardized procedures in group settings starting 2023, and 104 NPs (available 2026) can practice completely independently after three years as a 103 NP.

Restricted Practice States

In these states, you’re required to have physician supervision or delegation for all practice activities, including prescribing. The physician doesn’t necessarily co-sign every prescription in real-time, but you’re operating under their license and protocols.

Key restricted states:

• Texas: Requires a Prescriptive Authority Agreement with a physician. Additionally, Texas prohibits APRNs from prescribing Schedule II controlled substances (like stimulants) outside of hospital settings or hospice care. For anxiety treatment, you can prescribe benzodiazepines (Schedule IV) if authorized in your agreement, but stimulants for comorbid ADHD would require physician involvement.

• Florida: PMHNPs must practice under a written protocol with a physician. Florida has a 7-day supply limit for most controlled substance prescriptions by NPs, except psychiatric nurse practitioners treating mental health conditions are exempt from this limit. So you can prescribe a full 30-day supply of Xanax for a patient with panic disorder—but you still need that protocol agreement.

• Pennsylvania: Requires collaborative agreements for all NP practice and prescribing. Physicians must review a percentage of your charts (100% for Schedule II prescriptions within 24 hours), and they can supervise no more than four NPs at once.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What About Telehealth Prescribing? The Federal Factor

Even if your state allows you to prescribe independently, federal rules add another layer when prescribing controlled substances via telehealth. Here’s where it gets interesting:

The Ryan Haight Act (pre-COVID) required at least one in-person medical evaluation before prescribing controlled substances. But since the COVID-19 Public Health Emergency, the DEA has continuously extended temporary flexibilities allowing telehealth prescribing of controlled medications—including benzodiazepines for anxiety—without any in-person visit.

As of February 2026, these flexibilities have been extended through December 2026. This means both psychiatrists and PMHNPs (where state law allows) can initiate and manage benzodiazepine therapy for anxiety entirely via video visits. In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these rules.

The DEA is working on permanent regulations expected late 2026, likely introducing a special telemedicine prescribing registration rather than returning to the strict pre-pandemic requirements. For now, you can leverage telehealth fully—but stay alert to regulatory changes.

State-specific telehealth rules matter too:

• Florida expressly permits teleprescribing of Schedule II drugs for psychiatric disorders (a specific carve-out in statute), meaning anxiety treatment via telehealth is clearly allowed. However, Florida’s out-of-state telehealth provider registration does not permit prescribing controlled substances—you need a full Florida license for that.

• Texas prohibits telemedicine treatment of chronic pain with controlled substances, but anxiety treatment is explicitly not considered chronic pain management, so you’re in the clear for prescribing anxiolytics via telehealth.

• California and New York have no additional telehealth-specific restrictions beyond federal law and standard of care requirements.

PMHNP vs Psychiatrist: The Real Differences in Anxiety Prescribing

Let’s be direct about the practical differences:

What Psychiatrists (MD/DO) Can Do:

• Prescribe any anxiety medication in all 50 states without supervision
• No collaborative agreements or chart review requirements
• Can prescribe Schedule II-V controlled substances independently
• Practice telehealth across state lines with just a license (no local physician partner needed)

What PMHNPs Can Do:

• In FPA states: Everything a psychiatrist can do for anxiety medication management
• In reduced/restricted states: Prescribe anxiety medications including controlled substances if authorized by their collaborative agreement and state law permits
• Face additional hurdles in states like Texas (no outpatient Schedule II) or Pennsylvania (mandatory chart reviews for controlled substances)
• Often reimbursed at 85% of physician rates by Medicare (though this can be mitigated by practice efficiency)

Here’s the reality check: A PMHNP in New York treating anxiety has essentially the same prescriptive authority as a psychiatrist. A PMHNP in Texas faces meaningful restrictions and must maintain an ongoing physician relationship. The gap between MD and NP authority ranges from non-existent to significant depending entirely on geography.

The Economics: What This Means for Your Practice

Understanding prescribing authority isn’t just about legality—it affects your earning potential and practice model.

Reimbursement snapshot for medication management (2026):

• Medicare pays approximately $202 for an initial psychiatric evaluation (90792)
• A 15-minute medication follow-up (99213) pays around $95 under Medicare
• PMHNPs are reimbursed at 85% of physician rates when billing Medicare directly (e.g., $81 for that same 90792)
• Private insurance typically pays 100-150% of Medicare rates
• Medicaid pays significantly less—often 50-60% of Medicare rates

The platform advantage: Instead of spending $3,000-5,000/month on marketing to acquire patients (SEO takes 6-12 months to produce results; Google Ads for mental health keywords run $15-40+ per click with most clicks not converting), platforms like Klarity operate on a pay-per-appointment model. You pay a standard listing fee only when a pre-qualified patient books with you.

No upfront marketing spend. No wasted ad budget. No billing headaches. You control your schedule and only pay when you see patients—that’s guaranteed ROI versus gambling on marketing channels where the true cost per acquired patient often exceeds $200-500 when you factor in all expenses, failed campaigns, and no-show rates.

For PMHNPs in states requiring collaboration, a platform can also handle the complexity of matching you with appropriate physician partners or ensuring compliance across state lines.

State-by-State Quick Reference

Making the Smart Choice for Your Anxiety Practice

Whether you’re an established psychiatrist or a PMHNP building your practice, understanding prescribing authority is foundational. But here’s what really matters: patient access and practice sustainability.

The psychiatric provider shortage is real—Texas has one psychiatrist for every 8,966 residents; Florida’s ratio is 1:8,577. Anxiety disorders are among the most common mental health conditions, and demand far exceeds supply. Telehealth platforms can help you reach underserved populations efficiently, but only if you’re practicing in the right states with the right authority.

Questions to ask yourself:

• Am I licensed in states where I can practice with the level of independence I want?
• Do I want to spend my time and money on marketing, billing, and patient acquisition—or just treating patients?
• If I’m an NP in a restricted state, do I have access to collaborative physicians who support telehealth anxiety treatment?
• What’s my actual cost per patient acquisition, and is there a better model?

For providers ready to focus on clinical care rather than business development, joining a platform that handles patient acquisition, credentialing, billing, and compliance can be transformative. Klarity Health matches you with pre-qualified anxiety patients, provides the telehealth infrastructure, and lets you practice within your state’s legal framework—whether that’s fully independent or with appropriate physician collaboration already in place.

You get to practice psychiatry. The platform handles everything else.

Frequently Asked Questions

Can psychiatric nurse practitioners prescribe Xanax and other benzodiazepines?

Yes, but it depends on your state. In Full Practice Authority states like New York or Arizona, PMHNPs can prescribe benzodiazepines independently. In states like Texas, Florida, or Pennsylvania, you need a collaborative agreement with a physician that explicitly authorizes controlled substance prescribing. You’ll also need a DEA registration in all cases.

What’s the difference between a PMHNP and a psychiatrist when prescribing anxiety medication?

Psychiatrists (MD/DO) can prescribe any anxiety medication independently in all states. PMHNPs have equivalent prescribing authority in FPA states, but face varying restrictions elsewhere—from needing collaborative agreements to limitations on specific drug classes. The clinical competency is comparable for routine anxiety management; the difference is regulatory.

Can I prescribe anxiety medications via telehealth?

Yes. Federal COVID-era flexibilities (extended through December 2026) allow prescribing of controlled substances including benzodiazepines via telehealth without an initial in-person visit. State laws vary—most allow it, but a few have additional requirements. Always check your state’s telehealth prescribing rules and PDMP requirements.

Do I need a collaborative agreement to prescribe SSRIs for anxiety?

SSRIs are not controlled substances, so requirements are less stringent than for benzodiazepines. However, in Reduced or Restricted practice states, you’ll still need a collaborative agreement or supervision to prescribe any medication, including SSRIs. Full Practice Authority states allow independent SSRI prescribing.

How much does it cost to acquire anxiety patients through traditional marketing?

The real cost is much higher than most providers expect. SEO requires 6-12 months of investment ($2,000-4,000/month for agency services) before generating consistent patient flow. Google Ads cost $15-40+ per click with conversion rates around 2-5%—meaning a booked patient costs $200-400+ after factoring in wasted clicks. Psychology Today and similar directories charge monthly fees plus compete hundreds of providers on the same page. Total monthly marketing spend typically runs $3,000-5,000 with uncertain ROI, versus platforms where you pay only when patients book.

What states are best for PMHNPs who want to prescribe anxiety medications independently?

Look for Full Practice Authority states: New York (changed 2022), Arizona, Washington, Oregon, Colorado, Maryland, and about 20 others. Illinois offers a path to FPA after experience. Avoid or be prepared for collaboration requirements in Texas, Pennsylvania, Florida (for now), and other restricted states if you want maximum autonomy.

Ready to Build Your Anxiety Practice Without the Marketing Headaches?

Klarity Health connects psychiatrists and PMHNPs with patients seeking anxiety treatment—without the upfront marketing costs, billing complexity, or patient acquisition gamble. You control your schedule. We handle the rest.

Join Klarity’s Provider Network →

Sources and References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov) – Official government source on federal telehealth prescribing policy, January 2, 2026

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov) – State law defining NP scope and telehealth rules, 2024 Statutes

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov) – State regulatory guidance on new NP independent practice categories, Updated 2024

4. NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com) – Professional association update on New York law changes, April 9, 2022

5. NursePractitionerLicense.com – Illinois NP Licensure & Limitations – Industry educational resource citing Illinois state law for NP practice authority, Updated February 12, 2024

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs